Inter Pharma PCL

Inter Pharma PCL EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Inter Pharma PCL (IP.BK) as of Oct 12, 2026 is 171.40 M THB. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 75.53 M THB — a change of 126.93% (higher).

EBITDA

171.40 MTHB

YoY

126.93%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Inter Pharma PCL is 2025 171.40 M THB. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Inter Pharma PCL was 2024 75.53 M THB. It decreases by 126.93% higher compared to the previous year.

The Inter Pharma PCL EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
40.96 M THB
Jan 1, 2019
61.54 M THB
Jan 1, 2020
78.33 M THB
Jan 1, 2021
145.77 M THB
Jan 1, 2022
171.70 M THB
Jan 1, 2023
109.40 M THB
Jan 1, 2024
75.53 M THB
Jan 1, 2025
171.40 M THB
The Inter Pharma PCL EBITDA history
YEAREBITDAYoY
171.40 MTHB+126.93%
75.53 MTHB-30.96%
109.40 MTHB-36.28%
171.70 MTHB+17.79%
145.77 MTHB+86.09%
78.33 MTHB+27.28%
61.54 MTHB+50.25%
40.96 MTHB+43.04%
28.64 MTHB+4.59%
27.38 MTHB+52.60%
17.94 MTHB—
Access this data via the Eulerpool API
Get Free API Key

Inter Pharma PCL Stock analysis

What does Inter Pharma PCL do? Inter Pharma PCL is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Inter Pharma PCL stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Inter Pharma PCL is 171.40 M THB in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Inter Pharma PCL changed from 75.53 M THB to 171.40 M THB, representing a 126.93% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Inter Pharma PCL since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s THB is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Inter Pharma PCL historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Inter Pharma PCL

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Inter Pharma PCL